These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1902110)

  • 1. Studies on the mechanism of resistance to mitomycin C and porfiromycin in a human cell strain derived from a cancer-prone individual.
    Marshall RS; Paterson MC; Rauth AM
    Biochem Pharmacol; 1991 May; 41(9):1351-60. PubMed ID: 1902110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DT-diaphorase activity and mitomycin C sensitivity in non-transformed cell strains derived from members of a cancer-prone family.
    Marshall RS; Paterson MC; Rauth AM
    Carcinogenesis; 1991 Jul; 12(7):1175-80. PubMed ID: 1906377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions.
    Marshall RS; Paterson MC; Rauth AM
    Br J Cancer; 1989 Mar; 59(3):341-6. PubMed ID: 2467684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of NAD(P)H:quinone oxidoreductase in mitomycin C- and porfiromycin-resistant HCT 116 human colon-cancer cells.
    Pan SS; Akman SA; Forrest GL; Hipsher C; Johnson R
    Cancer Chemother Pharmacol; 1992; 31(1):23-31. PubMed ID: 1458556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the mechanistic aspects of mitomycin antibiotic bioactivation in Chinese hamster ovary cells overexpressing NADPH:cytochrome C (P-450) reductase and DT-diaphorase.
    Belcourt MF; Hodnick WF; Rockwell S; Sartorelli AC
    Adv Enzyme Regul; 1998; 38():111-33. PubMed ID: 9762350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells.
    Fracasso PM; Sartorelli AC
    Cancer Res; 1986 Aug; 46(8):3939-44. PubMed ID: 3089583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-dependent inactivation of DT-diaphorase by mitomycin C and porfiromycin.
    Siegel D; Beall H; Kasai M; Arai H; Gibson NW; Ross D
    Mol Pharmacol; 1993 Dec; 44(6):1128-34. PubMed ID: 8264549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxygen and exposure kinetics as factors influencing the cytotoxicity of porfiromycin, a mitomycin C analogue, in Chinese hamster ovary cells.
    Marshall RS; Rauth AM
    Cancer Res; 1988 Oct; 48(20):5655-9. PubMed ID: 3167822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chinese hamster ovary cell lines resistant to mitomycin C under aerobic but not hypoxic conditions are deficient in DT-diaphorase.
    Dulhanty AM; Whitmore GF
    Cancer Res; 1991 Apr; 51(7):1860-5. PubMed ID: 1900739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of DT-diaphorase in mitomycin C resistance in human colon cancer cell lines.
    Lambert PA; Kang Y; Greaves B; Perry RR
    J Surg Res; 1998 Dec; 80(2):177-81. PubMed ID: 9878310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitomycin C is not metabolized by but is an inhibitor of human kidney NAD(P)H: (quinone-acceptor)oxidoreductase.
    Schlager JJ; Powis G
    Cancer Chemother Pharmacol; 1988; 22(2):126-30. PubMed ID: 3136941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the metabolism and cytotoxicity of bioreductive alkylating agents by dicoumarol in aerobic and hypoxic murine tumor cells.
    Keyes SR; Rockwell S; Sartorelli AC
    Cancer Res; 1989 Jun; 49(12):3310-3. PubMed ID: 2470504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapeutic attack of hypoxic tumor cells by the bioreductive alkylating agent mitomycin C.
    Keyes SR; Heimbrook DC; Fracasso PM; Rockwell S; Sligar SG; Sartorelli AC
    Adv Enzyme Regul; 1985; 23():291-307. PubMed ID: 3934922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased sensitivity of quinone resistant cells to mitomycin C.
    Begleiter A; Robotham E; Lacey G; Leith MK
    Cancer Lett; 1989 Jun; 45(3):173-6. PubMed ID: 2471583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1.
    Keyes SR; Fracasso PM; Heimbrook DC; Rockwell S; Sligar SG; Sartorelli AC
    Cancer Res; 1984 Dec; 44(12 Pt 1):5638-43. PubMed ID: 6437671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porfiromycin as a bioreductive alkylating agent with selective toxicity to hypoxic EMT6 tumor cells in vivo and in vitro.
    Keyes SR; Rockwell S; Sartorelli AC
    Cancer Res; 1985 Aug; 45(8):3642-5. PubMed ID: 3926306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells.
    Siegel D; Gibson NW; Preusch PC; Ross D
    Cancer Res; 1990 Dec; 50(23):7483-9. PubMed ID: 1701346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased DT-diaphorase expression and cross-resistance to mitomycin C in a series of cisplatin-resistant human ovarian cancer cell lines.
    O'Dwyer PJ; Perez RP; Yao KS; Godwin AK; Hamilton TC
    Biochem Pharmacol; 1996 Jul; 52(1):21-7. PubMed ID: 8678904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the superoxide dismutase inhibitor, diethyldithiocarbamate, on the cytotoxicity of mitomycin antibiotics.
    Pritsos CA; Keyes SR; Sartorelli AC
    Cancer Biochem Biophys; 1989 Oct; 10(4):289-98. PubMed ID: 2559790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.